{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:10:05Z","timestamp":1795090205871,"version":"4.10.2"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.drugalcdep.2020.108310","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T17:10:22Z","timestamp":1600794622000},"page":"108310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence"],"prefix":"10.1016","volume":"216","author":[{"given":"Lisa L.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shainnel O.","family":"Eans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana C.","family":"Brice-Tutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Stacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe A.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-2381","authenticated-orcid":false,"given":"Francisco","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-4039","authenticated-orcid":false,"given":"Abhisheak","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3454-1310","authenticated-orcid":false,"given":"Edward W.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie A.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-9342","authenticated-orcid":false,"given":"Jay P.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108310_bib0005","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2174\/156802611795371305","article-title":"Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity","volume":"11","author":"Adkins","year":"2011","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"29","key":"10.1016\/j.drugalcdep.2020.108310_bib0010","doi-asserted-by":"crossref","first-page":"748","DOI":"10.15585\/mmwr.mm6529a4","article-title":"Notes from the field: kratom (Mitragyna speciosa) exposures reported to poison centers\u2014United States, 2010\u20132015","volume":"65","author":"Anwar","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"04","key":"10.1016\/j.drugalcdep.2020.108310_bib0015","first-page":"340","article-title":"Comparative pharmacokinetics of mitragynine after oral administration of Mitragyna speciosa (Kratom) leaf extracts in rats","volume":"85","author":"Avery","year":"2018","journal-title":"Planta Medica"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108310_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2007.03.028","article-title":"Opioid dependence and addiction during opioid treatment of chronic pain","volume":"129","author":"Ballantyne","year":"2007","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108310_bib0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self\u2010treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"issue":"18","key":"10.1016\/j.drugalcdep.2020.108310_bib0030","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1111\/bph.15165","article-title":"Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behavior","volume":"177","author":"Brice-Tutt","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0035","series-title":"CDC WONDER","article-title":"National Vital Statistics System, Mortality","author":"CDC\/NCHS","year":"2018"},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108310_bib0040","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/ajp.143.7.831","article-title":"The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone","volume":"143","author":"Charney","year":"1986","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0045","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fphar.2019.00678","article-title":"Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain","volume":"10","author":"Cirino","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0050","series-title":"Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 \u2013 Identifier NCT03414099, \u201cKetum and Pain Tolerance\u201d","author":"ClinicalTrials.gov [internet]","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0055","series-title":"Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 \u2013 Identifier NCT04392011, \u201cAssessing the Pharmacokinetics and Drug Interaction Liability of Kratom, an Opioid-like Natural Product\u201d","author":"ClinicalTrials.gov [internet]","year":"2020"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108310_bib0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-143-8-200510180-00028","article-title":"Prescribing methadone as an analgesic","volume":"143","author":"Dart","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108310_bib0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0022-3565(25)10187-0","article-title":"The kappa opioid agonist U-50, 488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats","volume":"264","author":"Dosaka-Akita","year":"1993","journal-title":"J Pharmacol Exp. Ther"},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108310_bib0070","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1021\/jm501637c","article-title":"Parallel synthesis of hexahydrodiimidazodiazepines heterocyclic peptidomimetics and their in vitro and in vivo activities at \u03bc (MOR), \u03b4 (DOR), and \u03ba (KOR) opioid receptors","volume":"58","author":"Eans","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108310_bib0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00508810","article-title":"Quantitative assessment of tolerance to and dependence on morphine in mice","volume":"297","author":"Fernandes","year":"1977","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0080","series-title":"Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers","first-page":"7","author":"Food and Drug Administration","year":"2005"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107849","article-title":"Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic","volume":"208","author":"Garcia-Romeu","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"8090","key":"10.1016\/j.drugalcdep.2020.108310_bib0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(78)92823-4","article-title":"Clonidine blocks acute opiate-withdrawal symptoms","volume":"312","author":"Gold","year":"1978","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108310_bib0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.2044-8341.1932.tb01062.x","article-title":"The effect of mitragynine on man","volume":"12","author":"Grewal","year":"1932","journal-title":"British Journal of Medical Psychology"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108310_bib0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan","year":"2013","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fpsyt.2020.00411","article-title":"Mitragynine Attenuates Morphine Withdrawal Effects in Rats\u2014A Comparison With Methadone and Buprenorphine","volume":"11","author":"Hassan","year":"2020","journal-title":"Frontiers in Psychiatry"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108310_bib0110","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/adb.12639","article-title":"Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7\u2010hydroxymitragynine","volume":"24","author":"Hemby","year":"2018","journal-title":"Addiction Biology"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0115","series-title":"50 Studies Every Psychiatrist Should Know","first-page":"309","article-title":"Methadone Maintenance versus Detoxification and Psychosocial Treatment for Opioid Dependence","author":"Hicks","year":"2018"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108310_bib0120","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00213-019-05247-7","article-title":"The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats","volume":"236","author":"Hiranita","year":"2019","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108310_bib0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/bmc.731","article-title":"A high\u2010performance liquid chromatographic method for determination of mitragynine in serum and its application to a pharmacokinetic study in rats","volume":"21","author":"Janchawee","year":"2007","journal-title":"Biomedical Chromatography"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108310_bib0130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archpsyc.1985.01790340041006","article-title":"Clonidine in morphine withdrawal: differential effects on signs and symptoms","volume":"42","author":"Jasinski","year":"1985","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108310_bib0135","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/00498254.2018.1552819","article-title":"Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)","volume":"49","author":"Kamble","year":"2019","journal-title":"Xenobiotica"},{"issue":"15","key":"10.1016\/j.drugalcdep.2020.108310_bib0140","doi-asserted-by":"crossref","first-page":"PL223","DOI":"10.1016\/S0024-3205(97)00074-X","article-title":"Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes","volume":"60","author":"Kamei","year":"1997","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108310_bib0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/ani4010035","article-title":"Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research","volume":"4","author":"Kilkenny","year":"2014","journal-title":"Animals"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108310_bib0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(98)00064-7","article-title":"Drug dependence: stress and dysregulation of brain reward pathways","volume":"51","author":"Kreek","year":"1998","journal-title":"Drug and Alcohol Dependence-Shannon"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108310_bib0155","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108310_bib0160","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel","year":"2019","journal-title":"ACS Central Science"},{"issue":"1-3","key":"10.1016\/j.drugalcdep.2020.108310_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.01.017","article-title":"Emerging drug targets for pain treatment","volume":"681","author":"Li","year":"2012","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108310_bib0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13181-016-0588-y","article-title":"Suspected adulteration of commercial kratom products with 7-hydroxymitragynine","volume":"12","author":"Lydecker","year":"2016","journal-title":"Journal of Medical Toxicology"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108310_bib0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(25)06637-2","article-title":"Pharmacology of opioids","volume":"35","author":"Martin","year":"1983","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108310_bib0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(96)00714-5","article-title":"Central antinociceptive effects of mitragynine in mice: Contribution of descending noradrenergic and serotonergic systems","volume":"317","author":"Matsumoto","year":"1996","journal-title":"European Journal of Pharmacology"},{"issue":"6603","key":"10.1016\/j.drugalcdep.2020.108310_bib0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the \u03bc-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108310_bib0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2006.09.020","article-title":"In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine+ naloxone, lofexidine+ placebo, and methadone","volume":"88","author":"McCambridge","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108310_bib0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","article-title":"Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based Kratom alkaloids","volume":"63","author":"Obeng","year":"2020","journal-title":"J Med Chem."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108310_bib0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/NUR.0000000000000392","article-title":"Think kratom is a safe opioid substitute? Think again!: History, evidence, and possible future for Mitragyna speciosa","volume":"32","author":"O\u2019Malley","year":"2018","journal-title":"Clinical Nurse Specialist"},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108310_bib0205","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck","year":"2012","journal-title":"The Journal of the American Osteopathic Association"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108310_bib0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1208\/s12248-010-9191-3","article-title":"Identification of two novel, potent, low-liability antinociceptive compounds from the direct in vivo screening of a large mixture-based combinatorial library","volume":"12","author":"Reilley","year":"2010","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.111876","article-title":"Self-reported prevalence and severity of opioid and kratom (Mitragyna speciosa korth.) side effects","volume":"238","author":"Saref","year":"2019","journal-title":"Journal of Ethnopharmacology"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108310_bib0220","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.3390\/ijms130911427","article-title":"Antinociceptive action of isolated mitragynine from Mitragyna speciosa through activation of opioid receptor system","volume":"13","author":"Shamima","year":"2012","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108310_bib0225","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/dta.2604","article-title":"Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra\u2010performance liquid chromatography\u2212 tandem mass spectrometry","volume":"11","author":"Sharma","year":"2019","journal-title":"Drug Testing and Analysis"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108310_bib0230","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1523\/JNEUROSCI.22-09-03663.2002","article-title":"Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal","volume":"22","author":"Shaw-Lutchman","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112462","article-title":"Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users","volume":"249","author":"Singh","year":"2020","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.drugalcdep.2020.108310_bib0240","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2014.03.017","article-title":"Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users","volume":"139","author":"Singh","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108310_bib0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0306-4603(90)90054-2","article-title":"Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts","volume":"15","author":"Strang","year":"1990","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108310_bib0250","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/02791072.2015.1096434","article-title":"Experiences of kratom users: a qualitative analysis","volume":"47","author":"Swogger","year":"2015","journal-title":"Journal of Psychoactive Drugs"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108310_bib0255","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/jm010576e","article-title":"Studies on the Synthesis and Opioid Agonistic Activities of Mitragynine-Related Indole Alkaloids: Discovery of Opioid Agonists Structurally Different from Other Opioid Ligands","volume":"45","author":"Takayama","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"issue":"18","key":"10.1016\/j.drugalcdep.2020.108310_bib0260","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2","volume":"59","author":"V\u00e1radi","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108310_bib0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","article-title":"The pharmacology and toxicology of kratom: from traditional herb to drug of abuse","volume":"130","author":"Warner","year":"2016","journal-title":"International Journal of Legal Medicine"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108310_bib0270","doi-asserted-by":"crossref","first-page":"e0174272","DOI":"10.1371\/journal.pone.0174272","article-title":"Locomotor activity: a distinctive index in morphine self-administration in rats","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS one"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:10:16Z","timestamp":1759828216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620304750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":54,"alternative-id":["S0376871620304750"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108310","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108310"}}